Literature DB >> 10899439

Oxidative stress in Alzheimer's disease.

M A Smith1, C A Rottkamp, A Nunomura, A K Raina, G Perry.   

Abstract

Oxidative balance is emerging as an important issue in understanding the pathogenesis of Alzheimer's disease. Examination of Alzheimer's disease brain has demonstrated a great deal of oxidative damage, associated with both hallmark pathologies (senile plaques and neurofibrillary tangles) as well as in normal appearing pyramidal neurons. While this suggests that oxidative stress is a proximal event in Alzheimer's disease pathogenesis, the mechanisms by which redox balance is altered in the disease remains elusive. Determining which of the proposed sources of free radicals, which include mitochondrial dysfunction, amyloid-beta-mediated processes, transition metal accumulation and genetic factors like apolipoprotein E and presenilins, is responsible for redox imbalance will lead to a better understanding of Alzheimer's disease pathogenesis and novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899439     DOI: 10.1016/s0925-4439(00)00040-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  162 in total

Review 1.  Oxidative stress, cell cycle, and neurodegeneration.

Authors:  Jeffrey A Klein; Susan L Ackerman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases.

Authors:  Gary E Gibson; Hsueh-Meei Huang
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 3.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

Review 4.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 5.  Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

Review 6.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Development of a neuroprotective potential algorithm for medicinal plants.

Authors:  Weixi Liu; Hang Ma; Nicholas A DaSilva; Kenneth N Rose; Shelby L Johnson; Lu Zhang; Chunpeng Wan; Joel A Dain; Navindra P Seeram
Journal:  Neurochem Int       Date:  2016-09-29       Impact factor: 3.921

Review 8.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

9.  Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease.

Authors:  Qingli Shi; Hui Xu; Wayne A Kleinman; Gary E Gibson
Journal:  Biochim Biophys Acta       Date:  2007-12-31

10.  Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice.

Authors:  Dong-Li Zhang; Yi-Qun Chen; Xu Jiang; Ting-Ting Ji; Bing Mei
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.